Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Financial Flexibility Index
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Financial Flexibility Index of 0.44x as of September 2025. Free cash flow of CN¥336.28 Million (operating CF CN¥281.88 Million minus capex CN¥54.40 Million) represents 0% of total liabilities (CN¥757.69 Million). Check Shaanxi Meibang Pharmaceutical Group Co asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shaanxi Meibang Pharmaceutical Group Co Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Shaanxi Meibang Pharmaceutical Group Co Ltd across 8 annual periods. See 605033 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Shaanxi Meibang Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see market cap of Shaanxi Meibang Pharmaceutical Group Co .
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.60x | CN¥439.21 Million | CN¥280.40 Million | CN¥737.37 Million | ▼ -36.1% |
| 2023 | 0.93x | CN¥538.48 Million | CN¥334.79 Million | CN¥577.84 Million | ▲ +87.5% |
| 2022 | 0.50x | CN¥235.70 Million | CN¥126.41 Million | CN¥474.14 Million | ▲ +11190.3% |
| 2021 | 0.00x | CN¥-2.23 Million | CN¥-108.75 Million | CN¥496.43 Million | ▼ -101.1% |
| 2020 | 0.41x | CN¥136.58 Million | CN¥74.88 Million | CN¥336.50 Million | ▼ -26.1% |
| 2019 | 0.55x | CN¥162.23 Million | CN¥128.45 Million | CN¥295.34 Million | ▲ +228.0% |
| 2018 | 0.17x | CN¥51.82 Million | CN¥16.96 Million | CN¥309.40 Million | ▲ +17.4% |
| 2017 | 0.14x | CN¥46.96 Million | CN¥29.41 Million | CN¥329.23 Million | — |